Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
infliximab
Email alerts
infliximab
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
Marcin
Stajszczyk
,
Izabela
Obarska
,
Slawomir
Jeka
,
Bogdan
Batko
Annals of the Rheumatic Diseases
Sep 2023,
82
(9)
1171-1180;
DOI:
10.1136/ard-2022-223696
Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’
Li-Tzu
Wang
,
Kevin Sheng-Kai
Ma
Annals of the Rheumatic Diseases
Dec 2022,
81
(12)
e254;
DOI:
10.1136/annrheumdis-2020-218995
Neuroinflammatory events after anti-TNFα therapy
Evripidis
Kaltsonoudis
,
Eleftherios
Pelechas
,
Paraskevi V
Voulgari
,
Alexandros A
Drosos
Annals of the Rheumatic Diseases
May 2022,
81
(5)
e73;
DOI:
10.1136/annrheumdis-2020-217723
Feasibility of 1 hour infliximab infusions
R F
van Vollenhoven
,
E
Gullström
,
L
Klareskog
Annals of the Rheumatic Diseases
Apr 2005,
64
(4)
654;
DOI:
10.1136/ard.2003.017590
Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis
J
Sany
,
M J
Kaiser
,
C
Jorgensen
,
G
Trape
Annals of the Rheumatic Diseases
Nov 2005,
64
(11)
1647-1649;
DOI:
10.1136/ard.2005.037499
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C
Antoni
,
G G
Krueger
,
K
de Vlam
,
C
Birbara
,
A
Beutler
,
C
Guzzo
,
B
Zhou
,
L T
Dooley
,
A
Kavanaugh
Annals of the Rheumatic Diseases
Aug 2005,
64
(8)
1150-1157;
DOI:
10.1136/ard.2004.032268
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P
Durez
,
A
Nzeusseu Toukap
,
B R
Lauwerys
,
D H
Manicourt
,
P
Verschueren
,
R
Westhovens
,
J-P
Devogelaer
,
F A
Houssiau
Annals of the Rheumatic Diseases
Sep 2004,
63
(9)
1069-1074;
DOI:
10.1136/ard.2003.012914
Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment
Gregory
Harriman
,
Lesley K
Harper
,
Thomas F
Schaible
Annals of the Rheumatic Diseases
Nov 1999,
58
(suppl 1)
I61-I64;
DOI:
10.1136/ard.58.2008.i61
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
H
Marzo-Ortega
,
D
McGonagle
,
S
Jarrett
,
G
Haugeberg
,
E
Hensor
,
P
O’Connor
,
A L
Tan
,
P G
Conaghan
,
A
Greenstein
,
P
Emery
Annals of the Rheumatic Diseases
Nov 2005,
64
(11)
1568-1575;
DOI:
10.1136/ard.2004.022582
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
C
Alessandri
,
M
Bombardieri
,
N
Papa
,
M
Cinquini
,
L
Magrini
,
A
Tincani
,
G
Valesini
Annals of the Rheumatic Diseases
Oct 2004,
63
(10)
1218-1221;
DOI:
10.1136/ard.2003.014647
Pages
1
2
3
next ›
last »
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)